My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Tesla, XPeng Build Humanoid Robotics, While N...
Palantir CTO Warns AI Safety ‘Effective Altru...
Sam Altman’s AI Nightmare Splits ETF Trade: B...
Top Economist Warns Odds of a 'Serious' Fed P...
TotalEnergies Bets Over $115 Million on AI to...
AI Slowdown Talk Turns Tech’s Biggest ‘Losers...
Middle-Aged Americans Are Filing for Bankrupt...
Elon Musk Says 'Excitement’ is Guaranteed at...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    JOHNSON & JOHNSON (NYSE: JNJ)

    Overview
    current price
    $267.20
    $267.20
    change
    0.88 | 0.33%
    0.88 | 0.33%
    Yesterday's Close
    266.32
    open
    265.81
    volume
    5.28 M
    30d. avg volume.
    6.32 M
    1 day
    260.68 - 267.20
    52 weeks
    173.33 - 281.07
    p/e
    30.90
    beta
    0.2439
    market cap
    641.80 B
    dividend yield
    2.01%
    Industry
    -
    JNJ by TradingView
    News and Commentary
    Johnson & Johnson Secures FDA Approval For First Rare Anemia Treatment On Tuesday, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson's
    One Blue-Chip Stock Is Up 11% While the S&P 500 Struggles The S&P 500 has had a rough 2026. Johnson & Johnson
    CVS Health's Lower Medical Cost Ratio Lift Profit, Outlook CVS Health Corp. (CVS
    Male Labor Force Participation Slumps As US Job Growth Tilts Toward Healthcare A growing gap in male labor force participation is raising fresh concerns about the strength and composition of the U.S. economy, as economists point to a slowdown that is dispro...
    Johnson & Johnson Posts Solid Q1 To Kickstart 'Year Of Accelerating Growth,' Says Bullish Analyst Johnson & Johnson (JNJ
    Market Update: Stocks Rise on Extended Ceasefire Optimism Stocks rose higher Monday as market participants held onto optimism that the United States and Iran will reach a peace deal over the next couple of days.
    Microsoft Is Now The Biggest Deadweight On S&P 500 — And Exxon Is What Nvidia Used To Be Microsoft Corp. (MSFT
    Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report The Trump administration is reportedly preparing to announce 100% tariffs on pharmaceutical companies that have not secured pricing deals with the White House.
    Johnson & Johnson Expects 2026 Sales To Hit Almost $100 Billion Johnson & Johnson (JNJ
    Market Update: Dow Rallies 560 Points to Record Close The Dow Jones Industrial Average soared to a new record closing high on Tuesday as market participants rotated out of technology names into stocks with lower valuations.
    StockTwits
    StockTwits
    Most Shared
    Dollar Tree Says Higher Fuel Prices Are Becoming a ‘Very, Very Meaningful’ Headwind
    Apple iPhone Duo Starts at $1,999 With 7.6-Inch Foldable Display: AAPL CEO John Ternus Says No More ‘Two Phones Awkwardly Stuck Together’
    AI's Half-Trillion-Dollar Borrowing Binge Is Competing With Uncle Sam for Bond Buyers
    Most Popular
    AI's Half-Trillion-Dollar Borrowing Binge Is Competing With Uncle Sam for Bond Buyers
    Fed September Hike Odds Spike to 59% After Warsh’s Hawkish Jackson Hole Speech
    Alibaba Stock Falls 7% on Profit Miss, but Analyst Stays Bullish on AI Cloud
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Microsoft
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?